SANTA CLARA, Calif., Nov. 12, 2012 /PRNewswire/ -- Cephasonics, Inc., a technology-innovation leader focused on delivering mixed-signal semiconductors, modules and subsystems to the imaging and ultrasound markets, today announced the release of the Cephasonics ultrasound application-programming interface (CS-API) software Version 3.0. Combined with Cephasonics' Quest™ (CSK9130) front-end beamforming system, it enables OEMs to develop ultrasound-based products for medical and imaging applications quickly and easily. CS-API V3.0 incorporates new and enhanced functions, including parallel beamforming; Doppler modes such as color-flow mapping (CFM), power-Doppler imaging (PDI), and pulsed-wave Doppler (PWD); duplex/triplex modes; and PCI-Express host-interface support. Cephasonics will demonstrate its latest embedded-ultrasound technology at Medica in Dusseldorf, Germany in Hall 16, booth C04, November 14-17 and at RSNA in Chicago in Hall B, booth 9525, November 25-30.
"This new release of our powerful ultrasound API software provides a more robust feature set and makes it simpler for our customers to develop innovative ultrasound-based application-specific solutions built around our Quest embedded beamforming front-end system," said Richard Tobias, CEO and founder of Cephasonics.
CS-API Version 3.0 Highlights
New and enhanced features include:
"The Quest (CSK9130) embedded-ultrasound engine with its feature-rich API allows users to control thousands of system parameters," said Danny Kreindler, senior director of marketing at Cephasonics. "Users can develop their software with a choice of three programming interfaces that provide different levels of abstraction to the underlying platform and different levels of system-parameter control." The system is completely self-contained and includes all necessary analog transmit/receive circuitry, beam formation, high-voltage power supplies, mid-processing functions, back-end host and probe interfaces.
The new CS-API V3.0 software will be available in the first quarter of 2013 from Cephasonics and its worldwide network of distribution partners. The company provides a free development and production license to use the software with the purchase of Quest series front-end systems.
Cephasonics, Inc. provides a complete range of technology, semiconductor and subsystem products that increase the performance, lower the power and accelerate time-to-market of ultrasound devices. Launched with a management buyout of Samplify Systems' Ultrasound Business Unit and headquartered in Santa Clara, Calif., the company's technology and semiconductor products, including its AutoFocus™ beamforming technology and its SAM1600 family of ADCs, have won multiple industry awards for innovation. Additional information about Cephasonics can be found at www.cephasonics.com.
Quest, AutoFocus, QuadBeam and FrameViewer are trademarks of Cephasonics.
|SOURCE Cephasonics, Inc.|
Copyright©2012 PR Newswire.
All rights reserved